193 related articles for article (PubMed ID: 11305608)
1. Possible changes in expression of chemotaxin LECT2 mRNA in mouse liver after concanavalin A-induced hepatic injury.
Segawa Y; Itokazu Y; Inoue N; Saito T; Suzuki K
Biol Pharm Bull; 2001 Apr; 24(4):425-8. PubMed ID: 11305608
[TBL] [Abstract][Full Text] [Related]
2. Strain difference in the induction of T-cell activation-associated, interferon gamma-dependent hepatic injury in mice.
Mizuhara H; Kuno M; Seki N; Yu WG; Yamaoka M; Yamashita M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
Hepatology; 1998 Feb; 27(2):513-9. PubMed ID: 9462651
[TBL] [Abstract][Full Text] [Related]
3. D-galactosamine-induced mouse hepatic apoptosis: possible involvement with tumor necrosis factor, but not with caspase-3 activity.
Itokazu Y; Segawa Y; Inoue N; Omata T
Biol Pharm Bull; 1999 Oct; 22(10):1127-30. PubMed ID: 10549870
[TBL] [Abstract][Full Text] [Related]
4. Increase in hepatic NKT cells in leukocyte cell-derived chemotaxin 2-deficient mice contributes to severe concanavalin A-induced hepatitis.
Saito T; Okumura A; Watanabe H; Asano M; Ishida-Okawara A; Sakagami J; Sudo K; Hatano-Yokoe Y; Bezbradica JS; Joyce S; Abo T; Iwakura Y; Suzuki K; Yamagoe S
J Immunol; 2004 Jul; 173(1):579-85. PubMed ID: 15210819
[TBL] [Abstract][Full Text] [Related]
5. The protective action of scutellarin against immunological liver injury induced by concanavalin A and its effect on pro-inflammatory cytokines in mice.
Tan ZH; Yu LH; Wei HL; Liu GT
J Pharm Pharmacol; 2007 Jan; 59(1):115-21. PubMed ID: 17227628
[TBL] [Abstract][Full Text] [Related]
6. Macrophage inflammatory protein-2 induced by TNF-alpha plays a pivotal role in concanavalin A-induced liver injury in mice.
Nakamura K; Okada M; Yoneda M; Takamoto S; Nakade Y; Tamori K; Aso K; Makino I
J Hepatol; 2001 Aug; 35(2):217-24. PubMed ID: 11580144
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1--relevance for concanavalin A-induced hepatitis.
Wolf D; Hallmann R; Sass G; Sixt M; Küsters S; Fregien B; Trautwein C; Tiegs G
J Immunol; 2001 Jan; 166(2):1300-7. PubMed ID: 11145713
[TBL] [Abstract][Full Text] [Related]
8. Effect of diphenyl dimethyl bicarboxylate on concanavalin A-induced liver injury in mice.
Gao M; Zhang J; Liu G
Liver Int; 2005 Aug; 25(4):904-12. PubMed ID: 15998443
[TBL] [Abstract][Full Text] [Related]
9. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A.
Küsters S; Gantner F; Künstle G; Tiegs G
Gastroenterology; 1996 Aug; 111(2):462-71. PubMed ID: 8690213
[TBL] [Abstract][Full Text] [Related]
10. Immunopathogenesis of hepatic fibrosis in chronic liver injury induced by repeatedly administered concanavalin A.
Kimura K; Ando K; Ohnishi H; Ishikawa T; Kakumu S; Takemura M; Muto Y; Moriwaki H
Int Immunol; 1999 Sep; 11(9):1491-500. PubMed ID: 10464170
[TBL] [Abstract][Full Text] [Related]
11. Glutathione peroxidase 1 deficiency attenuates concanavalin A-induced hepatic injury by modulation of T-cell activation.
Lee DH; Son DJ; Park MH; Yoon DY; Han SB; Hong JT
Cell Death Dis; 2016 Apr; 7(4):e2208. PubMed ID: 27124582
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Fas/FasL mRNA expression and TNF-alpha release in concanavalin A-induced liver injury in mice by bicyclol.
Li M; Liu GT
World J Gastroenterol; 2004 Jun; 10(12):1775-9. PubMed ID: 15188504
[TBL] [Abstract][Full Text] [Related]
13. Alleviation of lipopolysaccharide/d-galactosamine-induced liver injury in leukocyte cell-derived chemotaxin 2 deficient mice.
Okumura A; Saito T; Tobiume M; Hashimoto Y; Sato Y; Umeyama T; Nagi M; Tanabe K; Unoki-Kubota H; Kaburagi Y; Hasegawa H; Miyazaki Y; Yamagoe S
Biochem Biophys Rep; 2017 Dec; 12():166-171. PubMed ID: 29090278
[TBL] [Abstract][Full Text] [Related]
14. Expression of cytokine mRNA in extrahepatic organs in a mouse concanavalin A-hepatitis model.
Okamoto T; Nakano Y; Asakura W; Kobayashi T; Tsuzuike N; Hara K
Jpn J Pharmacol; 1998 Jul; 77(3):219-25. PubMed ID: 9717769
[TBL] [Abstract][Full Text] [Related]
15. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines.
Fiorucci S; Santucci L; Antonelli E; Distrutti E; Del Sero G; Morelli O; Romani L; Federici B; Del Soldato P; Morelli A
Gastroenterology; 2000 Feb; 118(2):404-21. PubMed ID: 10648469
[TBL] [Abstract][Full Text] [Related]
16. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice.
Toyabe S; Seki S; Iiai T; Takeda K; Shirai K; Watanabe H; Hiraide H; Uchiyama M; Abo T
J Immunol; 1997 Aug; 159(3):1537-42. PubMed ID: 9233653
[TBL] [Abstract][Full Text] [Related]
17. Beraprost sodium, a prostacyclin (PGI) analogue, ameliorates concanavalin A-induced liver injury in mice.
Ohta S; Nakamuta M; Fukushima M; Kohjima M; Kotoh K; Enjoji M; Nawata H
Liver Int; 2005 Oct; 25(5):1061-8. PubMed ID: 16162167
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with dihydroquercetin, a dietary flavonoid, protected against concanavalin A-induced immunological hepatic injury in mice and TNF-α/ActD-induced apoptosis in HepG2 cells.
Chen J; Sun X; Xia T; Mao Q; Zhong L
Food Funct; 2018 Apr; 9(4):2341-2352. PubMed ID: 29589006
[TBL] [Abstract][Full Text] [Related]
19. Induction of thymocyte apoptosis by systemic administration of concanavalin A in mice: role of TNF-alpha, IFN-gamma and glucocorticoids.
Fayad R; Sennello JA; Kim SH; Pini M; Dinarello CA; Fantuzzi G
Eur J Immunol; 2005 Aug; 35(8):2304-12. PubMed ID: 16047339
[TBL] [Abstract][Full Text] [Related]
20. Salvianolic acid A preconditioning confers protection against concanavalin A-induced liver injury through SIRT1-mediated repression of p66shc in mice.
Xu X; Hu Y; Zhai X; Lin M; Chen Z; Tian X; Zhang F; Gao D; Ma X; Lv L; Yao J
Toxicol Appl Pharmacol; 2013 Nov; 273(1):68-76. PubMed ID: 23993977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
